BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21116502)

  • 41. Matrix metalloproteinases-1 and -2, and tissue inhibitor of metalloproteinase-2 production is abnormal in bone marrow stromal cells of multiple myeloma patients.
    Zdzisińska B; Walter-Croneck A; Kandefer-Szerszeń M
    Leuk Res; 2008 Nov; 32(11):1763-9. PubMed ID: 18472160
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation of matrix metalloproteinases and their inhibitors with hypoxia and angiogenesis in premenopausal patients with adenocarcinoma of the breast.
    Vinothini G; Aravindraja C; Chitrathara K; Nagini S
    Clin Biochem; 2011 Aug; 44(12):969-74. PubMed ID: 21620816
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma.
    Manenti L; Paganoni P; Floriani I; Landoni F; Torri V; Buda A; Taraboletti G; Labianca R; Belotti D; Giavazzi R
    Eur J Cancer; 2003 Sep; 39(13):1948-56. PubMed ID: 12932675
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension.
    Lepetit H; Eddahibi S; Fadel E; Frisdal E; Munaut C; Noel A; Humbert M; Adnot S; D'Ortho MP; Lafuma C
    Eur Respir J; 2005 May; 25(5):834-42. PubMed ID: 15863640
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decreases in plasma MMP-2/TIMP-2 and MMP-9/TIMP-1 ratios in uremic patients during hemodialysis.
    Lu LC; Yang CW; Hsieh WY; Chuang WH; Lin YC; Lin CS
    Clin Exp Nephrol; 2016 Dec; 20(6):934-942. PubMed ID: 26711243
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alterations in regulators of the extracellular matrix in non-Hodgkin lymphomas.
    Negaard HF; Svennevig K; Kolset SO; Iversen N; Lothe IM; Østenstad B; Sandset PM; Iversen PO
    Leuk Lymphoma; 2009 Jun; 50(6):998-1004. PubMed ID: 19373600
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of metalloproteinases and their tissue inhibitors in squamous cell laryngeal carcinoma.
    Christopoulos TA; Papageorgakopoulou N; Ravazoula P; Mastronikolis NS; Papadas TA; Theocharis DA; Vynios DH
    Oncol Rep; 2007 Oct; 18(4):855-60. PubMed ID: 17786346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasma MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation. The effect of aprotinin and the relation to ischemia/reperfusion injury.
    Kuyvenhoven JP; Molenaar IQ; Verspaget HW; Veldman MG; Palareti G; Legnani C; Moolenburgh SE; Terpstra OT; Lamers CB; van Hoek B; Porte RJ
    Thromb Haemost; 2004 Mar; 91(3):506-13. PubMed ID: 14983226
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metalloproteinases and Their Inhibitors in Patients with Inguinal Hernia.
    Isik A; Gursul C; Peker K; Aydın M; Fırat D; Yılmaz İ
    World J Surg; 2017 May; 41(5):1259-1266. PubMed ID: 28050662
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum levels of matrix metalloproteinases MMP-2 and MMP-9 and their tissue natural inhibitors in breast tumors.
    Jinga D; Stefanescu M; Blidaru A; Condrea I; Pistol G; Matache C
    Roum Arch Microbiol Immunol; 2004; 63(3-4):141-58. PubMed ID: 17240786
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The balance between MMP-2/-9 and TIMP-1/-2 is shifted towards MMP in renal cell carcinomas and can be further disturbed by hydrogen peroxide.
    Hemmerlein B; Johanns U; Halbfass J; Böttcher T; Heuser M; Radzun HJ; Thelen P
    Int J Oncol; 2004 May; 24(5):1069-76. PubMed ID: 15067327
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of matrix metalloproteinases and related tissue inhibitors in the cyst fluids of ovarian mucinous neoplasms.
    Furuya M; Ishikura H; Kawarada Y; Ogawa Y; Sakuragi N; Fujimoto S; Yoshiki T
    Gynecol Oncol; 2000 Aug; 78(2):106-12. PubMed ID: 10926788
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heparin affects matrix metalloproteinases and tissue inhibitors of metalloproteinases circulating in peripheral blood.
    Mannello F; Jung K; Tonti GA; Canestrari F
    Clin Biochem; 2008 Dec; 41(18):1466-73. PubMed ID: 18926810
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) and their tissue inhibitors (TIMP-1 and TIMP-2) in differential diagnosis between low malignant potential (LMP) and malignant ovarian tumours.
    Määtta M; Talvensaari-Mattila A; Turpeenniemi-Hujanen T; Santala M
    Anticancer Res; 2007; 27(4C):2753-8. PubMed ID: 17695443
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging.
    Baker EA; Bergin FG; Leaper DJ
    Br J Surg; 2000 Sep; 87(9):1215-21. PubMed ID: 10971431
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of matrix metalloproteinases 2, 7 and 9, and their tissue inhibitors 1 and 2, in developing rabbit tracheae.
    Miller TL; Touch SM; Singhaus CJ; Ramesh Babu PB; Chidekel A; Shaffer TH
    Biol Neonate; 2006; 89(4):236-43. PubMed ID: 16319450
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.
    Rysz J; Banach M; Stolarek RA; Pasnik J; Cialkowska-Rysz A; Koktysz R; Piechota M; Baj Z
    J Nephrol; 2007; 20(4):444-52. PubMed ID: 17879211
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [How to predict the relapse after surgery or radiofrequency of liver metastases of colorectal cancer? Interest of the serum kinetic variation of a matrix metalloproteinase cluster].
    Frenoux C; Rebischung C; Quesada JL; Mendosa C; Letoublon C; Trocmé C
    Bull Cancer; 2018 Oct; 105(10):884-895. PubMed ID: 30243479
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduced expression of tissue inhibitor of metalloproteinase in nodal metastasis of stomach cancer.
    Ko BK; Cho HR; Choi DW; Nam CW; Park CJ; Kim GY; Kim SS; Woo YJ; Huh J; Kim MY
    J Korean Med Sci; 1998 Jun; 13(3):286-90. PubMed ID: 9681807
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic value of MMP-2, -9 and TIMP-1,-2 immunoreactive protein at the invasive front in advanced head and neck squamous cell carcinomas.
    Ondruschka C; Buhtz P; Motsch C; Freigang B; Schneider-Stock R; Roessner A; Boltze C
    Pathol Res Pract; 2002; 198(8):509-15. PubMed ID: 12389993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.